Micron Technology, Inc. (MU) Earnings
Micron Technology, Inc. is expected to report next earnings on June 24, 2026 (in NaN days), with a consensus EPS estimate of $19.62. MU has beaten EPS estimates in 11 of its last 12 reported quarters (average surprise +19.7% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Mar 18, 2026 | $9.19 | $12.20 | +32.8% | $23.9B | +19.5% |
| Dec 17, 2025 | $3.96 | $4.78 | +20.7% | $13.6B | +5.7% |
| Sep 23, 2025 | $2.86 | $3.03 | +5.9% | $11.3B | +0.9% |
| Jun 25, 2025 | $1.60 | $1.91 | +19.4% | $9.3B | +4.9% |
| Mar 20, 2025 | $1.43 | $1.56 | +9.1% | $8.1B | +2.0% |
| Dec 18, 2024 | $1.75 | $1.79 | +2.3% | $8.7B | -0.1% |
| Sep 25, 2024 | $1.12 | $1.18 | +5.4% | $7.8B | +1.3% |
| Mar 20, 2024 | $-0.25 | $0.42 | +266.2% | $5.8B | +8.9% |
| Dec 20, 2023 | $-0.99 | $-0.95 | +4.0% | $4.7B | -1.7% |
| Dec 21, 2022 | $-0.01 | $-0.04 | -194.6% | $4.1B | -1.2% |
| Jun 30, 2022 | $2.43 | $2.59 | +6.6% | $8.6B | -0.0% |
| Dec 20, 2021 | $2.11 | $2.16 | +2.4% | $7.7B | +2.2% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q2 FY2026 · March 18, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Strategic pillars: Driving commercial adoption - 2025 was a record year of installed base expansion with 340 new accounts added, closing the year with 1,465 U.S. accounts. Advancing plaque innovation pipeline - Drove strong early momentum in plaque account additions, closed 2025 with 489 accounts, launched next generation plaque algorithm, pulled forward PCI Navigator launch to April 2026, and announced AI-driven efficiency initiative Partflow Autonomous Processing. Extending clinical leadership - Accelerate evidence generation through prospective trials and peer-reviewed publications, launched Navigate PCI registry, presented real world data from Mass General Brigham plaque registry, plan to report one-year outcomes from DECIDE registry, and plan to expand into high-risk asymptomatic population with three randomized controlled trials.
Guidance
Initiating full year 2026 revenue guidance in the range of $218 million to $222 million. Initiating non-GAAP gross margin guidance of 80% to 81%. Increasing midterm non-GAAP gross margin target from 80% to 85%. PLAC revenue for 2026 is expected to be approximately $15 million to $17 million, weighted towards the back half.
Segment performance
Total fourth quarter revenue was $49.1 million, representing more than a 40% year-over-year growth. Global cases grew nearly 53% year-over-year. Achieved a record non-GAAP gross margin of nearly 80%. Initiating full year 2026 revenue guidance in the range of $218 million to $222 million, representing a year-over-year growth of approximately 24 to 26 percent. Full-year 2026 PLAC revenue is expected to reach approximately $15 million to $17 million. Initiating full year 2026 non-GAAP gross margin guidance of 80 to 81%, and increasing midterm non-GAAP gross margin target to 85%.
Analyst Q&A
Q: Robbie Marcus with JPM asked about 2026 guidance and plaque,
A: John Farquhar responded on confidence in the business, drivers of FFRCT growth, plaque progress.
Q: William Plovnik with Canaccord Genuity asked about product innovations and PCI Navigator,
A: John Farquhar talked about product innovations like next gen plaque algorithm, PCI Navigator launch, and Vikram Virghese discussed FFRCT case numbers and guidance phasing.
Q: Matthew O'Brien with Piper Sandler asked about plaque revenue per case and gross margin,
A: John Farquhar and Vikram Virghese spoke about plaque pricing, gross margin drivers.
Q: Larry Bigelson with Wells Fargo asked about plaque utilization and clinical data,
A: John Farquhar discussed plaque utilization and clinical education efforts.
Q: Rick Wise with Stifel asked about CCTA adoption and competition,
A: John Farquhar talked about CCTA adoption progress and competitive positioning focusing on data and product quality